NORTH HAVEN, Conn.--(BUSINESS WIRE)--As the rate of Type 2 Diabetes soars to epidemic proportions worldwide, Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the Our Resolution movement, a collaboration of healthcare experts, nonprofit organizations, health agencies, patients and national spokespersons who share the goal of resolving Type 2 Diabetes.
